Perspective Therapeutics (CATX) FCF Margin (2010 - 2023)

Perspective Therapeutics (CATX) has 14 years of FCF Margin data on file, last reported at 185.58% in Q4 2023.

• For the quarter ending Q4 2023, FCF Margin changed N/A year-over-year to 185.58%; the trailing twelve-month figure through Dec 2023 stood at 4489.95% (changed N/A YoY), and the FY2023 full-year result was 2648.88%, changed N/A from the prior year.
• FCF Margin rose to 185.58% in Q4 2023, from 473.09% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 185.58% in Q4 2023 to a low of 575.13% in Q2 2023.
• A 5-year average of 107.07% and a median of 52.88% in 2019 frame the typical range for FCF Margin.
• Across the five-year window, FCF Margin jumped 13302 bps in 2021 and plunged 49303 bps in 2023, its largest moves.
• Tracing CATX's FCF Margin over 5 years: stood at 62.74% in 2019, then soared by 45 bps to 34.76% in 2020, then surged by 383 bps to 98.26% in 2021, then sank by 190 bps to 88.32% in 2022, then soared by 310 bps to 185.58% in 2023.
• Business Quant data shows CATX's FCF Margin at 185.58% in Q4 2023, 473.09% in Q3 2023, and 575.13% in Q2 2023.